๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia

โœ Scribed by David Ng; Ousmane Toure; Laura Fontaine; Mary L. McMaster; Lynn R. Goldin; Neil Caporaso; Jorge R. Toro

Book ID
108674196
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
53 KB
Volume
137
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interleukin-1B (IL1B) and interleukin-6
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia
โœ Maria G. Ennas; Patrick S. Moore; Mariagrazia Zucca; Emanuele Angelucci; Maria G ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 1 views

## Abstract Common polymorphisms in genes encoding for cytokines implicated in the inflammatory response and Th1/Th2 balance might play a role in the development and prognosis of chronic lymphocytic leukaemia (CLL). To test the hypothesis, we investigated 13 single nucleotide polymorphisms (SNPs) i

Investigation of an NQO1 polymorphism as
Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia
โœ Asher Begleiter; Donna Hewitt; Spencer B. Gibson; James B. Johnston ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 395 KB

NAD(P)H:quinoneoxidoreductase 1 (NQO1) inhibits some cancers and increases p53 and apoptosis in cells. Due to an inactivating polymorphism, 10% of humans have no NQO1 activity. A case:control study suggested that chronic lymphocytic leukemia (CLL) patients may have an increased incidence of the NQO1